Open original FDA record ↗Recall record
- FDA identifier
- Z-0101-2014
- Company in FDA record
- HemoCue AB
- FDA classification date
- Oct 29, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
HemoCue AB has become aware of a production related problem involving punctured HemoCue Hb 201 Microcuvettes single pack pouches.
Source facts
- Action
- On 8/13/2013 the firm sent Field Safety Notices to their customers.
- Initiated
- 2013-07-25
- Root cause
- Packaging
- Terminated
- 2014-08-11
- Distribution
- Worldwide distribution which includes the following states: AK, AL, AS, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY,MD, ME, MI, MN, MO, NC, ND, NE, NJ, NM, NY, OH, OK, OR, SC, SD, TN, TX, UT, VA, WA, WI, VT, WV & WY and the countries of Armenia, Australia, Austria, Belgium, Cyprus, Czech Republic, Denmark, El Salvador Finland, France, Germany, Great Britain, Guatemala, Hong Kong, Israel, Ivory Coast, Netherlands, New Zealand, Norway, Peru, Poland, Russia, South Africa, Sweden, Switzerland and Taiwan.
- Recall number
- Z-0101-2014
- Recall status
- Terminated
- CDRH record ID
- 120868
- FDA classified
- 2013-10-29
- Recall event number
- 65920